Abstract.
Erythropoietic protoporphyria (EPP) is an inherited disorder, caused by a partial deficiency of ferrochelatase (FECH), the last enzyme of the heme biosynthetic pathway. The deficiency results in accumulation of protoporphyrin, primarily in erythroid cells, and the major clinical feature is cutaneous photosensitivity. In addition, some patients may develop liver complications. Several EPP-coupled mutations have been identified in the FECH gene, and the less than 50% of FECH activity seen in patients with overt EPP was recently shown to be due to the in trans inheritance of one deleterious mutation and a IVS3-48T>C transition in intron 3 of the FECH gene. This IVS3-48T>C transition modulates the use of a constitutive aberrant splice site, which results in a decreased FECH mRNA level in the carrier. In the present study, the inheritance of four novel (364C>T, 393delC, 532G>A, and 1088-89insGG) and two previously reported (343C>T and 1001C>T) FECH mutations, and the splice site modulator IVS3-48C was investigated in nine Swedish families with EPP. The methods used for the FECH gene analysis included denaturating gradient gel electrophoresis, sequencing analysis, and restriction enzyme cleavage. Haplotype analysis, based on the polymorphic loci 287(G/A), IVS3-48(T/C), and 921(G/A), revealed that all individuals carrying a mutated allele and IVS3-48C in trans to each other were affected by overt EPP. Mild clinical and biochemical EPP signs may, however, be present in individuals carrying a T at position IVS3-48 in trans to a mutated allele, because this was the case in one of the individuals investigated in the present study.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: September 9, 2002 / Accepted: November 11, 2002
Acknowledgments This work was supported by a stipend fund from HemeBiotech A/S, Hillerød, Denmark and by grants from the Swedish Porphyria Association and the Karolinska Institute.
Correspondence to:Å. Wiman
Rights and permissions
About this article
Cite this article
Wiman, Å., Floderus, Y. & Harper, P. Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria. J Hum Genet 48, 70–76 (2003). https://doi.org/10.1007/s100380300009
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380300009
This article is cited by
-
The incidence of inherited porphyrias in Europe
Journal of Inherited Metabolic Disease (2013)
-
Erythropoietic protoporphyria
Orphanet Journal of Rare Diseases (2009)
-
Gene Dosage Analysis Identifies Large Deletions of the FECH Gene in 10% of Families with Erythropoietic Protoporphyria
Journal of Investigative Dermatology (2007)
-
Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria
Current Treatment Options in Gastroenterology (2007)
-
Novel Ferrochelatase Mutations in Japanese Patients with Erythropoietic Protoporphyria: High Frequency of the Splice Site Modulator IVS3–48C Polymorphism in the Japanese Population
Journal of Investigative Dermatology (2006)